Vitalgenics sources mesenchymal stem cells (MSCs) that originate from donated umbilical cords via our laboratory partner. In researching MSCs, you will find they possess the highest concentrations of nucleated cells capable of continually creating growth factors and related proteins. These growth factors and proteins play a large part in the potency of the stem cells.

Yes, and yes. The stem cells sourced by Vitalgenics are derived from umbilical cord blood that would normally be discarded after the delivery of a baby. Neither the baby nor the delivering mother is harmed in any way. Many of the controversies surrounding ‘stem cells’ relates to embryonic stem cells (see our guide to different stem cell types). Vitalgenics does not source or endorse the use of embryonic stem cells.

Absolutely. Especially in the realms of pain management and orthopedics. Dozens of treatments have shown tremendous benefit to a multitude of different conditions, diseases, and disorders. See more details about conditions and treatments.

Stem cell treatments where the patient receives stem cells from a source other than their own tissue are called non-autologous. Non-autologous treatments are not ‘approved’ by the FDA, but regulated by them. The FDA has placed the responsibility of these treatments in the hands of practitioners who make the determination of whether the treatments are safe and clinically useful for the patient.

For the most part, Regenerative Medicine procedures and treatments are not covered by typical medical insurance. In certain instances, there may be parts of a surgery related to the Regenerative Medicine procedure that a given insurance company may cover. The general rule of thumb though is that most Regenerative Medicine procedures are considered a “self-pay” or “fee-for-service” procedure. Inquire with a Vitalgenics Practitioner to learn about some of our available financing options.

Vitalgenics Muse Cell–Derived Exosomes are produced from carefully selected, laboratory-cultured cell populations known as multilineage-differentiating stress-enduring (Muse) cells, which are recognized for their resilience and signaling characteristics. These cells are maintained under controlled, sterile conditions designed to support optimal cellular activity and the natural release of extracellular vesicles.

During the production process, exosomes are collected from the conditioned culture media after being secreted by the cells. The material then undergoes a series of purification and concentration steps to isolate extracellular vesicles of interest while removing unwanted components. Advanced analytical techniques are used to characterize particle size, concentration, and biological markers associated with exosomes.

Each batch is subjected to rigorous quality control and validation, including sterility, endotoxin, and mycoplasma testing, along with particle characterization methods such as Nanoparticle Tracking Analysis (NTA). The final product is then preserved under controlled conditions to maintain structural integrity and consistency prior to clinical use within a physician-directed care framework.

Exosomes are nano-sized extracellular vesicles naturally released by cells that play a key role in cell-to-cell communication. They carry bioactive molecules such as proteins, lipids, and genetic material (including mRNA and microRNA) that help regulate cellular signaling pathways. In regenerative medicine, exosome-based products are used within physician-directed care to support the body’s natural processes related to tissue environment modulation, recovery, and cellular communication.

Exosome-based therapies are an evolving area of research and are not currently FDA-approved for specific disease indications. However, they are subject to regulatory oversight, and their use in clinical practice is determined by licensed medical providers based on patient-specific evaluation, informed consent, and clinical judgment. Reputable providers utilize products that undergo rigorous quality testing, including sterility, endotoxin, and characterization analyses, to support safety and consistency.